Anti-SARS-CoV-2 Spike Antibody Response to the Fourth Dose of BNT162b2 mRNA COVID-19 Vaccine and Associated Factors in Japanese Hemodialysis Patients

Anti-SARS-CoV-2 Spike Antibody Response to the Fourth Dose of BNT162b2 mRNA COVID-19 Vaccine and Associated Factors in Japanese Hemodialysis Patients

Keiji Hirai,1 Masako Shimotashiro,2 Toshiaki Okumura,2 Susumu Ookawara,1 Yoshiyuki Morishita1 1Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan; 2Mizue Yuai Clinic, Tokyo, JapanCorrespondence: Keiji Hirai, Division of N...

Full description

Bibliographic Details
Main Authors: Hirai K, Shimotashiro M, Okumura T, Ookawara S, Morishita Y
Format: Article
Language:English
Published: Dove Medical Press 2024-05-01
Series:International Journal of Nephrology and Renovascular Disease
Subjects:
coronavirus disease 2019
severe acute respiratory syndrome coronavirus 2
anti-severe acute respiratory syndrome coronavirus 2 spike antibody
bnt162b2 messenger rna vaccine
hemodialysis
Online Access:https://www.dovepress.com/anti-sars-cov-2-spike-antibody-response-to-the-fourth-dose-of-bnt162b2-peer-reviewed-fulltext-article-IJNRD

Internet

https://www.dovepress.com/anti-sars-cov-2-spike-antibody-response-to-the-fourth-dose-of-bnt162b2-peer-reviewed-fulltext-article-IJNRD

Similar Items